Brandes Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-745,080
Closed -$3.9M 193
2023
Q4
$3.9M Sell
745,080
-389,283
-34% -$2.04M 0.06% 118
2023
Q3
$17.9M Buy
1,134,363
+293,276
+35% +$4.62M 0.35% 75
2023
Q2
$16.4M Buy
841,087
+296,037
+54% +$5.75M 0.33% 77
2023
Q1
$15.5M Buy
545,050
+128,873
+31% +$3.66M 0.33% 73
2022
Q4
$12.2M Sell
416,177
-51,680
-11% -$1.51M 0.34% 59
2022
Q3
$12.4M Buy
467,857
+3,565
+0.8% +$94.2K 0.32% 76
2022
Q2
$20.6M Buy
464,292
+32,442
+8% +$1.44M 0.5% 54
2022
Q1
$21.4M Sell
431,850
-182,515
-30% -$9.03M 0.46% 61
2021
Q4
$31.3M Sell
614,365
-58,711
-9% -$2.99M 0.68% 48
2021
Q3
$37.5M Sell
673,076
-43,797
-6% -$2.44M 0.81% 42
2021
Q2
$30.7M Buy
716,873
+227,246
+46% +$9.73M 0.68% 48
2021
Q1
$20.1M Buy
489,627
+225,230
+85% +$9.25M 0.48% 60
2020
Q4
$12.3M Buy
264,397
+109,473
+71% +$5.09M 0.32% 73
2020
Q3
$6.58M Buy
154,924
+147,833
+2,085% +$6.28M 0.23% 81
2020
Q2
$340K Sell
7,091
-143,510
-95% -$6.88M 0.01% 146
2020
Q1
$6.93M Buy
150,601
+145,413
+2,803% +$6.69M 0.24% 80
2019
Q4
$312K Buy
5,188
+57
+1% +$3.43K 0.01% 126
2019
Q3
$290K Sell
5,131
-2,262
-31% -$128K 0.01% 123
2019
Q2
$412K Sell
7,393
-14,585
-66% -$813K 0.01% 117
2019
Q1
$1.11M Buy
21,978
+668
+3% +$33.7K 0.03% 106
2018
Q4
$858K Buy
21,310
+17,652
+483% +$711K 0.02% 117
2018
Q3
$254K Sell
3,658
-8,327
-69% -$578K 0.01% 135
2018
Q2
$907K Sell
11,985
-13,234
-52% -$1M 0.02% 111
2018
Q1
$1.33M Buy
+25,219
New +$1.33M 0.03% 117